Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8290708 | 1.00 | CYP2C9 (0.38) | CYP2C9TSHRCYP2C19TDP1S1PR2 | |
| SCHEMBL4374384 | 0.87 | S1PR2 (0.32) | CYP2C9TSHRCYP2C19TDP1S1PR2 | |
| SCHEMBL13248929 | 0.87 | FUCA1 (0.37) | CYP2C9TSHRCYP2C19TDP1S1PR2 | |
| SCHEMBL1763282 | 0.87 | — | — | |
| SCHEMBL13535333 | 0.87 | — | — | |
| SCHEMBL2699869 | 0.84 | — | — | |
| SCHEMBL2699865 | 0.84 | — | — | |
| SCHEMBL2699867 | 0.84 | — | — | |
| SCHEMBL24449419 | 0.82 | — | — | |
| SCHEMBL22151837 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116516508-B | Special material for high melt index random copolymer polypropylene fiber and preparation method thereof | 锦州英诺威科技服务有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116516508-A | Special material for high melt index random copolymer polypropylene fiber and preparation method thereof | 锦州英诺威科技服务有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-114560846-B | Multifunctional chemical cross-linking agent and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2023-07-18 | — | — | CN | claimed |
| CN-103965381-B | A kind of titanium tetrachloride initiator system altogether and the method being used for preparing high-activity polyisobutylene thereof | 北京化工大学 | 2016-08-24 | — | — | CN | claimed |
| CN-103965381-A | Titanium tetrachloride co-initiation system, and method for preparing high-reaction-activity polyisobutylene by using it | UNIV BEIJING CHEMICAL | 2014-08-06 | — | — | CN | claimed |
| CN-101613423-B | Initiation system used for synthesizing polyisobutylene with high reaction activity | UNIV BEIJING CHEMICAL | 2011-05-18 | — | — | CN | claimed |
| CN-101613423-A | A kind of initiator system that is used for synthesizing polyisobutylene with high reaction activity | UNIV BEIJING CHEMICAL | 2009-12-30 | — | — | CN | claimed |
| US-4785100-A | BROMINATION FOLLOWED BY AMINATION | HUELS AKTIENGESELLSHAFT (DE) | 1988-11-15 | — | — | US | claimed |
| EP-0262348-A2 | Process for the preparation of N-substituted morpholine and piperidine derivatives | HÜLS AKTIENGESELLSCHAFT (DE) | 1988-04-06 | — | — | EP | claimed |
| US-4634687-A | COCATALYST FOR COORDINATION CATALYST | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1987-01-06 | — | — | US | claimed |
| US-20260092138-A1 | BLOCKED POLYISOCYANATE COMPOSITION, CURABLE RESIN COMPOSITION COMPRISING THE COMPOSITION, AND CURED PRODUCT | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20240287108-A1 | nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES | THE JOHNS HOPKINS UNIVERSITY | 2024-08-29 | — | — | US | disclosed |
| US-12037345-B2 | Heterobicyclic compounds for inhibiting the activity of SHP2 | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| CN-116516508-B | Special material for high melt index random copolymer polypropylene fiber and preparation method thereof | 锦州英诺威科技服务有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-116516508-A | Special material for high melt index random copolymer polypropylene fiber and preparation method thereof | 锦州英诺威科技服务有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-4382093-A | 9-Aminoalkylfluorenes | ELI LILLY AND COMPANY (US) | 1983-05-03 | — | — | US | disclosed |
| US-4281120-A | IMMUNE STIMULANTS | GRUNENTHAL GMBH (DE) | 1981-07-28 | — | — | US | disclosed |
| US-4277495-A | FLUORENE 9-AMINOALKYL-9-CARBOXYLIC ACIDS OR ESTERS | ELI LILLY AND COMPANY (US) | 1981-07-07 | — | — | US | disclosed |
| US-4070461-A | ANTICHOLESTEROL | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-01-24 | — | — | US | disclosed |
| US-3998808-A | INSECTICIDES, FUNGICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287108-A1 | nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES | SGMS2, SMPD2, CERS2 | CYP2C9 2616/4885TSHR 4859/4885CYP2C19 2869/4885 |
| US-20260092138-A1 | BLOCKED POLYISOCYANATE COMPOSITION, CURABLE RESIN COMPOSITION COMPRISING THE COMPOSITION, AND CURED PRODUCT | RER1, RPP30, REV1 | CYP2C9 1887/4885TSHR 3522/4885CYP2C19 2584/4885 |
| US-12037345-B2 | Heterobicyclic compounds for inhibiting the activity of SHP2 | PTPN1, PTPN9, PTPN7 | CYP2C9 2409/4885TSHR 1359/4885CYP2C19 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.